Page 1 | Search Results | Blood | American Society of Hematology

1-5 of 5

Sort by

Sort Order Select

Journal Articles

A Multi Center Trial of hyperCVAD+Rituxan in Patients with Newly Diagnosed Mantle Cell Lymphoma.

Elliot M. Epner, MD, PhD, Joseph Unger, PhD, Thomas Miller, MD, Lisa Rimzsa, PhD, Catherine Spier, MD, Michael Leblanc, PhD, Richard Fisher, MD

Blood (2007) 110 (11): 387.

https://doi.org/10.1182/blood.V110.11.387.387

Published: 2007

Journal Articles

Central Nervous System (CNS) Relapse in Agressive Non-Hodgkin’s Lymphoma; Does CNS Prophylaxis Work?.

Steven H. Bernstein, Joseph Unger, Micheal LeBlanc, Richard I. Fisher

Blood (2007) 110 (11): 520.

https://doi.org/10.1182/blood.V110.11.520.520

Published: 2007

Journal Articles

An Update of a Phase II Trial of CHOP Followed by Tositumomab/Iodine I-131 Tositumomab (Bexxar®) for Front-Line Treatment of Advanced Stage, Follicular Lymphoma: Southwest Oncology Group Protocol 9911.

Oliver W. Press, MD, PhD, Joseph Unger, David Maloney, MD, PhD, Rita M. Braziel, MD, Michael LeBlanc, PhD, Thomas Grogan, MD, Thomas P. Miller, MD, Richard I. Fisher, MD

Blood (2005) 106 (11): 352.

https://doi.org/10.1182/blood.V106.11.352.352

Published: 2005

Journal Articles

Impact of Increased Body Weight on Acute Toxicity and Outcome of Autologous Stem Cell Transplantation for Non-Hodgkin’s Lymphoma: A Southwest Oncology Group Analysis.

Patrick Stiff, MD, Joseph Unger, MS, Stephen Forman, MD, Michael LeBlanc, PhD, Thomas Miller, MD, Oliver Press, MD, John Thompson, MD, Richard Fisher, MD

Blood (2004) 104 (11): 352.

https://doi.org/10.1182/blood.V104.11.352.352

Published: 2004

Journal Articles

The Burkitt-like lymphomas: a Southwest Oncology Group study delineating phenotypic, genotypic, and clinical features

Rita M. Braziel, Daniel A. Arber, Marilyn L. Slovak, Margaret L. Gulley, Catherine Spier, Carl Kjeldsberg, Joseph Unger, Thomas P. Miller, Raymond Tubbs, Catherine Leith, Richard I. Fisher, Thomas M. Grogan

Blood (2001) 97 (12): 3713–3720.

https://doi.org/10.1182/blood.V97.12.3713

Published: 2001

NARROW

A Multi Center Trial of hyperCVAD+Rituxan in Patients with Newly Diagnosed Mantle Cell Lymphoma.

Central Nervous System (CNS) Relapse in Agressive Non-Hodgkin’s Lymphoma; Does CNS Prophylaxis Work?.

An Update of a Phase II Trial of CHOP Followed by Tositumomab/Iodine I-131 Tositumomab (Bexxar®) for Front-Line Treatment of Advanced Stage, Follicular Lymphoma: Southwest Oncology Group Protocol 9911.

Impact of Increased Body Weight on Acute Toxicity and Outcome of Autologous Stem Cell Transplantation for Non-Hodgkin’s Lymphoma: A Southwest Oncology Group Analysis.

The Burkitt-like lymphomas: a Southwest Oncology Group study delineating phenotypic, genotypic, and clinical features

Email alerts

ASH Publications

American Society of Hematology

A Multi Center Trial of hyperCVAD+Rituxan in Patients with Newly Diagnosed Mantle Cell Lymphoma.

Central Nervous System (CNS) Relapse in Agressive Non-Hodgkin’s Lymphoma; Does CNS Prophylaxis Work?.

An Update of a Phase II Trial of CHOP Followed by Tositumomab/Iodine I-131 Tositumomab (Bexxar®) for Front-Line Treatment of Advanced Stage, Follicular Lymphoma: Southwest Oncology Group Protocol 9911.

Impact of Increased Body Weight on Acute Toxicity and Outcome of Autologous Stem Cell Transplantation for Non-Hodgkin’s Lymphoma: A Southwest Oncology Group Analysis.

The Burkitt-like lymphomas: a Southwest Oncology Group study delineating phenotypic, genotypic, and clinical features

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only